DUBLIN, April 12, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recently received FDA de novo clearance for the GI Genius intelligence endoscopy module. GI Genius is ...

The GI Genius™ Intelligent Endoscopy Module Helps Transform Colorectal Cancer Detection in New York NEW YORK, August 17, 2023--(BUSINESS WIRE)--Kips Bay Endoscopy Center (KBEC), a Covenant Physician ...

(RTTNews) - Medtronic plc (MDT) announced the FDA granted de novo clearance for GI Genius intelligent endoscopy module in the United States. The GI Genius Module helps physicians in detecting ...

OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog, and display technology, today announced the availability of several new OVMed ® ...

New York, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gastrointestinal Endoscopy Market - A Global and Regional Analysis: Focus on Type, End User, and ...

Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Dublin, Ireland - 12 April 2021: Cosmo Pharmaceuticals NV (SIX: COPN) ...

NEW YORK--(BUSINESS WIRE)--Kips Bay Endoscopy Center (KBEC), a Covenant Physician Partner, will offer patients receiving a colonoscopy an enhanced screening with the aid of GI Genius™ intelligent ...

Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius(TM) intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The GI Genius ...

The GI Genius module FDA approval marks a pivotal milestone for Cosmo after more than 10 years of research and investments focused to generate disruptive innovations in the field of colon's disease ...